StockData
Equillium, Inc. logo

Equillium, Inc. (EQ) stock

EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.21+0.06 (+5.22%)

Close on Nov 17, 2026Market cap $76.72MP/E –Yield –

Equillium revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Equillium's revenue for the twelve months ending Dec 31, 2024 was $41.10M, up 13.9% year over year. For fiscal 2024 it was $41.10M, up 13.9% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$41.10M+13.9%
FY2023Dec 31, 2023$36.08M+129.0%
FY2022Dec 31, 2022$15.76M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$4.39M-52.3%
Q3 FY2024Sep 30, 2024$12.16M+37.1%
Q2 FY2024Jun 30, 2024$13.85M+51.8%
Q1 FY2024Mar 31, 2024$10.69M+20.4%
Q4 FY2023Dec 31, 2023$9.21M–
Q3 FY2023Sep 30, 2023$8.87M–
Q2 FY2023Jun 30, 2023$9.12M–
Q1 FY2023Mar 31, 2023$8.88M–

More Equillium figures

See a number that looks wrong?